1. Home
  2. IMKTA vs PHAR Comparison

IMKTA vs PHAR Comparison

Compare IMKTA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$69.81

Market Cap

1.3B

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$17.17

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMKTA
PHAR
Founded
1963
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMKTA
PHAR
Price
$69.81
$17.17
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$38.00
AVG Volume (30 Days)
114.5K
27.2K
Earning Date
02-05-2026
11-06-2025
Dividend Yield
0.96%
N/A
EPS Growth
N/A
N/A
EPS
4.40
0.00
Revenue
$5,334,032,609.00
$362,274,000.00
Revenue This Year
N/A
$25.19
Revenue Next Year
N/A
$4.47
P/E Ratio
$15.65
$3,085.37
Revenue Growth
N/A
26.78
52 Week Low
$58.92
$7.50
52 Week High
$78.59
$18.30

Technical Indicators

Market Signals
Indicator
IMKTA
PHAR
Relative Strength Index (RSI) 43.41 56.00
Support Level $67.92 $16.55
Resistance Level $70.83 $17.37
Average True Range (ATR) 1.51 0.67
MACD -0.09 -0.04
Stochastic Oscillator 32.21 73.19

Price Performance

Historical Comparison
IMKTA
PHAR

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: